Haiyan Liu

No 20 Xisi Road
Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

NAT10 contributes to the progression of multiple myeloma through ac4C modification of GPR37.

NAT10 contributes to the progression of multiple myeloma through ac4C modification of GPR37.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 11, 2025

Prognostic Significance of SGK1 Expression in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study.

Prognostic Significance of SGK1 Expression in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study.

Journal: Stem cells international

Published: June 27, 2025

Multiple Myeloma Side Population Cells Promote Dexamethasone Resistance of Main Population Cells through Exosome Metastasis of LncRNA SNHG16.

Multiple Myeloma Side Population Cells Promote Dexamethasone Resistance of Main Population Cells through Exosome Metastasis of LncRNA SNHG16.

Journal: Journal of oncology

Published: August 25, 2022

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.

Journal: Technology in cancer research & treatment

Published: January 31, 2022

Exosomal miR-483-5p in Bone Marrow Mesenchymal Stem Cells Promotes Malignant Progression of Multiple Myeloma by Targeting TIMP2.

Exosomal miR-483-5p in Bone Marrow Mesenchymal Stem Cells Promotes Malignant Progression of Multiple Myeloma by Targeting TIMP2.

Journal: Frontiers in cell and developmental biology

Published: January 26, 2022

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients.

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients.

Journal: Journal of hematology & oncology

Published: April 14, 2021

Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report.

Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report.

Journal: BMC pregnancy and childbirth

Published: January 05, 2021

ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.

ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.

Journal: Aging

Published: March 12, 2020

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: OncoTargets and therapy

Published: November 12, 2019

Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p.

Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p.

Journal: Cancer cell international

Published: October 05, 2019

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy.

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy.

Journal: OncoTargets and therapy

Published: July 18, 2019

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p.

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p.

Journal: BMC cancer

Published: January 03, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026